Fisher Paykel Healthcare | FPH

Stock Price
43.35
Daily Change
0.03 0.07%
Monthly
2.75%
Yearly
15.51%
Q3 Forecast
42.33



Peers Price Chg Day Year Date
Ansell 41.50 0.14 0.34% 22.78% Sep/15
A2 Milk 8.52 0.18 2.16% -17.28% Sep/15
Cochlear 136.43 -0.01 -0.01% -54.82% Sep/15
CSL 174.26 2.69 1.57% -13.69% Sep/15
EBOS 20.11 -0.07 -0.35% -30.17% Sep/15
Fisher Paykel Healthcare 43.35 0.03 0.07% 15.51% Sep/15
Healius 0.46 0.03 7.06% -41.29% Sep/15
Nanosonics 2.84 0.04 1.43% -30.56% Sep/15
Ramsay Health Care 53.57 0.65 1.23% 59.67% Sep/15
ResMed 31.37 0.87 2.85% -23.11% Sep/15

Indexes Price Day Year Date
NZX 50 13484 -76.47 -0.56% 1.88% Sep/15

Fisher Paykel Healthcare traded at 43.35 this Tuesday September 15th, increasing 0.03 or 0.07 percent since the previous trading session. Looking back, over the last four weeks, Fisher Paykel Healthcare gained 2.75 percent. Over the last 12 months, its price rose by 15.51 percent. Looking ahead, we forecast Fisher Paykel Healthcare to be priced at 42.33 by the end of this quarter and at 39.98 in one year, according to Trading Economics global macro models projections and analysts expectations.

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.